Irritable bowel syndrome trials in Japan
2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
- Where
- Chūōku, Isehara, Kobe, Sapporo, Shinjuku-Ku
- Age
- 18 years to 75 years
- People
- 342 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07545772 · EU 2025-524974-41-00 - Phase 2Taking peopleA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Where
- Chūōku, Fujiidera, Isehara, Kobe, Kumamoto, Sapporo, Shinjuku-Ku
- Age
- 18 years to 75 years
- People
- 531 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07545759 · EU 2025-524973-17-00